HOVON110/ReBeL Study: Results of the phase i part of a randomized phase I/II study of lenalidomide, rituximab with or without bendamustine in patients with relapsed/refractory follicular lymphoma

Wendy B. C. Stevens, Katerina Bakunina, Marloes Cuijpers, Martine Chamuleau, Aart Beeker, Rob Fijnheer, Holger Hebart, Hein P. J. Visser, Jeanette K. Doorduijn, Kim Linton, Martin Dreyling, Daphne de Jong, Marie José Kersten

Research output: Contribution to journalComment/Letter to the editorAcademic

3 Citations (Scopus)
Original languageEnglish
Article numbere325
JournalHemaSphere
Volume4
Issue number1
DOIs
Publication statusPublished - 2020

Cite this